General
Experience20 yrs
Elite Ratings
--
Practice Areas
Chemical Biotech (7 cases)
Biotech (36 cases)
Chemical (1 case)
Comp. Arch. and Software (1 case)
Communications (1 case)
Ratings
Experience
Grade
Trend
DCT
L3
E
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:24-CV-00587 | Acerta Pharma BV v. Cipla Ltd | 05/16/24 | Challenger | |
| 2:23-CV-00123 | Fennec Pharma Inc v. Cipla Ltd | 01/10/23 | Challenger | |
| 1:22-CV-00300 | Cipla Ltd v. Boehringer Ingelheim Intl GmbH | 03/04/22 | Challenger | |
| 1:22-CV-00162 | Acerta Pharma BV v. Cipla Ltd | 02/04/22 | Challenger | |
| 1:22-CV-00154 | Acerta Pharma BV v. Alembic Pharma Ltd | 02/02/22 | Challenger | |
| 1:21-CV-01229 | UCB Inc v. Cipla Ltd | 08/26/21 | Challenger | |
| 2:20-CV-10172 | Teva Branded Pharmaceutical Products R&D Inc v. Cipla Ltd | 08/07/20 | ||
| 2:19-CV-20810 | Cipla Ltd v. Novartis AG | 11/26/19 | Challenger | |
| 3:17-CV-08399 | Boehringer Ingelheim Pharma Inc v. MSN Laboratories Pvt Ltd | 10/16/17 | ||
| 2:16-CV-09074 | Abraxis Bioscience LLC v. Cipla Ltd | 12/07/16 |